VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q107637323  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241221010632.0
008     241221nneanz||abbn n and d
035 ‎‡a  (WKP)Q107637323‏
035 ‎‡a  (OCoLC)Q107637323‏
100 0 ‎‡a  John Giordano‏ ‎‡c  academic‏ ‎‡9  en‏
375 ‎‡a  1‏ ‎‡2  iso5218‏
670 ‎‡a  Author's Can the Chronic Administration of the Combination of Buprenorphine and Naloxone Block Dopaminergic Activity Causing Anti-reward and Relapse Potential?‏
670 ‎‡a  Author's Correction: Long Term Suboxone™ Emotional Reactivity As Measured by Automatic Detection in Speech.‏
670 ‎‡a  Author's Correlation of the Taq1 dopamine D2 receptor gene and percent body fat in obese and screened control subjects: a preliminary report‏
670 ‎‡a  Author's Coupling Genetic Addiction Risk Score‏
670 ‎‡a  Author's Coupling Genetic Addiction Risk Score (GARS) and Pro Dopamine Regulation (KB220) to Combat Substance Use Disorder (SUD)‏
670 ‎‡a  Author's Coupling Genetic Addiction Risk Score (GARS) with Electrotherapy: Fighting Iatrogenic Opioid Dependence‏
670 ‎‡a  Author's Critical Analysis of White House Anti-Drug Plan‏
670 ‎‡a  Author's Declinol, a Complex Containing Kudzu, Bitter Herbs (Gentian, Tangerine Peel) and Bupleurum, Significantly Reduced Alcohol Use Disorders Identification Test (AUDIT) Scores in Moderate to Heavy Drinkers: A Pilot Study‏
670 ‎‡a  Author's Diagnosis and Healing In Veterans Suspected of Suffering from Post-Traumatic Stress Disorder (PTSD) Using Reward Gene Testing and Reward Circuitry Natural Dopaminergic Activation‏
670 ‎‡a  Author's Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS).‏
670 ‎‡a  Author's "Dopamine homeostasis" requires balanced polypharmacy: Issue with destructive, powerful dopamine agents to combat America's drug epidemic‏
670 ‎‡a  Author's Drug abuse relapse rates linked to level of education: can we repair hypodopaminergic-induced cognitive decline with nutrient therapy?‏
670 ‎‡a  Author's Early intervention of intravenous KB220IV--neuroadaptagen amino-acid therapy (NAAT) improves behavioral outcomes in a residential addiction treatment program: a pilot study‏
670 ‎‡a  Author's Enhanced functional connectivity and volume between cognitive and reward centers of naïve rodent brain produced by pro-dopaminergic agent KB220Z.‏
670 ‎‡a  Author's Genospirituality: Our Beliefs, Our Genomes, and Addictions‏
670 ‎‡a  Author's Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE(R) device therapy: a case series‏
670 ‎‡a  Author's Hypothesizing Las Vegas and Sutherland Springs Mass Shooters Suffer from Reward Deficiency Syndrome: "Born Bad"‏
670 ‎‡a  Author's Hypothesizing repetitive paraphilia behavior of a medication refractive Tourette's syndrome patient having rapid clinical attenuation with KB220Z-nutrigenomic amino-acid therapy (NAAT).‏
670 ‎‡a  Author's Hypothesizing that a Pro-Dopaminergic Regulator‏
670 ‎‡a  Author's Hypothesizing that a Pro-Dopaminergic Regulator (KB220z™ Liquid Variant) can Induce "Dopamine Homeostasis" and Provide Adjunctive Detoxification Benefits in Opiate/Opioid Dependence‏
670 ‎‡a  Author's Hypothesizing that designer drugs containing cathinones‏
670 ‎‡a  Author's Hypothesizing that designer drugs containing cathinones ("bath salts") have profound neuro-inflammatory effects and dangerous neurotoxic response following human consumption‏
670 ‎‡a  Author's Iatrogenic opioid dependence is endemic and legal: Genetic addiction risk score‏
670 ‎‡a  Author's Iatrogenic opioid dependence is endemic and legal: Genetic addiction risk score (GARS) with electrotherapy a paradigm shift in pain treatment programs‏
670 ‎‡a  Author's Long term Suboxone™ emotional reactivity as measured by automatic detection in speech‏
670 ‎‡a  Author's Neuro-Genetics of Reward Deficiency Syndrome (RDS) as the Root Cause of "Addiction Transfer": A New Phenomenon Common after Bariatric Surgery‏
670 ‎‡a  Author's Neuro-psychopharmacogenetics and Neurological Antecedents of Posttraumatic Stress Disorder: Unlocking the Mysteries of Resilience and Vulnerability‏
670 ‎‡a  Author's Neurogenetics and Clinical Evidence for the Putative Activation of the Brain Reward Circuitry by a Neuroadaptagen: Proposing an Addiction Candidate Gene Panel Map‏
670 ‎‡a  Author's Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome‏
670 ‎‡a  Author's Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms‏
670 ‎‡a  Author's Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).‏
670 ‎‡a  Author's Neuropsychiatric Genetics of Happiness, Friendships, and Politics: Hypothesizing Homophily ("Birds of a Feather Flock Together") as a Function of Reward Gene Polymorphisms‏
670 ‎‡a  Author's Neuropsychopharmacology and neurogenetic aspects of executive functioning: should reward gene polymorphisms constitute a diagnostic tool to identify individuals at risk for impaired judgment?‏
670 ‎‡a  Author's NIDA-Drug Addiction Treatment Outcome Study (DATOS) Relapse as a Function of Spirituality/Religiosity‏
670 ‎‡a  Author's Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D₂ agonist therapy: part 2.‏
670 ‎‡a  Author's Overcoming qEEG Abnormalities and Reward Gene Deficits during Protracted Abstinence in Male Psychostimulant and Polydrug Abusers Utilizing Putative Dopamine D2Agonist Therapy: Part 2‏
670 ‎‡a  Author's Pilot clinical observations between food and drug seeking derived from fifty cases attending an eating disorder clinic‏
670 ‎‡a  Author's Sex, drugs, and rock 'n' roll: hypothesizing common mesolimbic activation as a function of reward gene polymorphisms‏
670 ‎‡a  Author's Test of variables of attention (TOVA) as a predictor of early attention complaints, an antecedent to dementia‏
670 ‎‡a  Author's The addictive brain: all roads lead to dopamine‏
670 ‎‡a  Author's The effects of residential dual diagnosis treatment on alcohol abuse.‏
670 ‎‡a  Author's The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery‏
670 ‎‡a  Author's Withdrawal from Buprenorphine/Naloxone and Maintenance with a Natural Dopaminergic Agonist: A Cautionary Note‏
919 ‎‡a  correctionlongtermsuboxonetmemotionalreactivityasmeasuredbyautomaticdetectioninspeech‏ ‎‡A  Correction: Long Term Suboxone™ Emotional Reactivity As Measured by Automatic Detection in Speech.‏ ‎‡9  1‏
919 ‎‡a  canthechronicadministrationofthecombinationofbuprenorphineandnaloxoneblockdopaminergicactivitycausingantirewardandrelapsepotential‏ ‎‡A  Can the Chronic Administration of the Combination of Buprenorphine and Naloxone Block Dopaminergic Activity Causing Anti-reward and Relapse Potential?‏ ‎‡9  1‏
919 ‎‡a  withdrawalfrombuprenorphinenaloxoneandmaintenancewithanaturaldopaminergicagonistacautionarynote‏ ‎‡A  Withdrawal from Buprenorphine/Naloxone and Maintenance with a Natural Dopaminergic Agonist: A Cautionary Note‏ ‎‡9  1‏
919 ‎‡a  molecularneurobiologyof12stepsprogramandfellowshipconnectingthedotsforrecovery‏ ‎‡A  The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery‏ ‎‡9  1‏
919 ‎‡a  effectsofresidentialdualdiagnosistreatmentonalcoholabuse‏ ‎‡A  The effects of residential dual diagnosis treatment on alcohol abuse.‏ ‎‡9  1‏
919 ‎‡a  addictivebrainallroadsleadtodopamine‏ ‎‡A  The addictive brain: all roads lead to dopamine‏ ‎‡9  1‏
919 ‎‡a  testofvariablesofattentiontovaasapredictorofearlyattentioncomplaintsanantecedenttodementia‏ ‎‡A  Test of variables of attention (TOVA) as a predictor of early attention complaints, an antecedent to dementia‏ ‎‡9  1‏
919 ‎‡a  sexdrugsandrocknrollhypothesizingcommonmesolimbicactivationasafunctionofrewardgenepolymorphisms‏ ‎‡A  Sex, drugs, and rock 'n' roll: hypothesizing common mesolimbic activation as a function of reward gene polymorphisms‏ ‎‡9  1‏
919 ‎‡a  pilotclinicalobservationsbetweenfoodanddrugseekingderivedfromfiftycasesattendinganeatingdisorderclinic‏ ‎‡A  Pilot clinical observations between food and drug seeking derived from fifty cases attending an eating disorder clinic‏ ‎‡9  1‏
919 ‎‡a  overcomingqeegabnormalitiesandrewardgenedeficitsduringprotractedabstinenceinmalepsychostimulantandpolydrugabusersutilizingputativedopamined2agonisttherapypart2‏ ‎‡A  Overcoming qEEG Abnormalities and Reward Gene Deficits during Protracted Abstinence in Male Psychostimulant and Polydrug Abusers Utilizing Putative Dopamine D2Agonist Therapy: Part 2‏ ‎‡9  2‏
919 ‎‡a  nidadrugaddictiontreatmentoutcomestudydatosrelapseasafunctionofspiritualityreligiosity‏ ‎‡A  NIDA-Drug Addiction Treatment Outcome Study (DATOS) Relapse as a Function of Spirituality/Religiosity‏ ‎‡9  1‏
919 ‎‡a  neuropsychopharmacologyandneurogeneticaspectsofexecutivefunctioningshouldrewardgenepolymorphismsconstituteadiagnostictooltoidentifyindividualsatriskforimpairedjudgment‏ ‎‡A  Neuropsychopharmacology and neurogenetic aspects of executive functioning: should reward gene polymorphisms constitute a diagnostic tool to identify individuals at risk for impaired judgment?‏ ‎‡9  1‏
919 ‎‡a  neuropsychiatricgeneticsofhappinessfriendshipsandpoliticshypothesizinghomophilybirdsofafeatherflocktogetherasafunctionofrewardgenepolymorphisms‏ ‎‡A  Neuropsychiatric Genetics of Happiness, Friendships, and Politics: Hypothesizing Homophily ("Birds of a Feather Flock Together") as a Function of Reward Gene Polymorphisms‏ ‎‡9  1‏
919 ‎‡a  neurogeneticsofdopaminergicreceptorsupersensitivityinactivationofbrainrewardcircuitryandrelapseproposingdeprivationamplificationrelapsetherapydart‏ ‎‡A  Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).‏ ‎‡9  1‏
919 ‎‡a  neurogeneticsandnutrigenomicsofneuronutrienttherapyforrewarddeficiencysyndromerdsclinicalramificationsasafunctionofmolecularneurobiologicalmechanisms‏ ‎‡A  Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms‏ ‎‡9  1‏
919 ‎‡a  neurogeneticsandnutrigenomicsofneuronutrienttherapyforrewarddeficiencysyndrome‏ ‎‡A  Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome‏ ‎‡9  1‏
919 ‎‡a  neurogeneticsandclinicalevidencefortheputativeactivationofthebrainrewardcircuitrybyaneuroadaptagenproposinganaddictioncandidategenepanelmap‏ ‎‡A  Neurogenetics and Clinical Evidence for the Putative Activation of the Brain Reward Circuitry by a Neuroadaptagen: Proposing an Addiction Candidate Gene Panel Map‏ ‎‡9  1‏
919 ‎‡a  neuropsychopharmacogeneticsandneurologicalantecedentsofposttraumaticstressdisorderunlockingthemysteriesofresilienceandvulnerability‏ ‎‡A  Neuro-psychopharmacogenetics and Neurological Antecedents of Posttraumatic Stress Disorder: Unlocking the Mysteries of Resilience and Vulnerability‏ ‎‡9  1‏
919 ‎‡a  neurogeneticsofrewarddeficiencysyndromerdsastherootcauseofaddictiontransferanewphenomenoncommonafterbariatricsurgery‏ ‎‡A  Neuro-Genetics of Reward Deficiency Syndrome (RDS) as the Root Cause of "Addiction Transfer": A New Phenomenon Common after Bariatric Surgery‏ ‎‡9  1‏
919 ‎‡a  longtermsuboxonetmemotionalreactivityasmeasuredbyautomaticdetectioninspeech‏ ‎‡A  Long term Suboxone™ emotional reactivity as measured by automatic detection in speech‏ ‎‡9  1‏
919 ‎‡a  iatrogenicopioiddependenceisendemicandlegalgeneticaddictionriskscoregarswithelectrotherapyaparadigmshiftinpaintreatmentprograms‏ ‎‡A  Iatrogenic opioid dependence is endemic and legal: Genetic addiction risk score (GARS) with electrotherapy a paradigm shift in pain treatment programs‏ ‎‡9  1‏
919 ‎‡a  iatrogenicopioiddependenceisendemicandlegalgeneticaddictionriskscore‏ ‎‡A  Iatrogenic opioid dependence is endemic and legal: Genetic addiction risk score‏ ‎‡9  1‏
919 ‎‡a  hypothesizingthatdesignerdrugscontainingcathinonesbathsaltshaveprofoundneuroinflammatoryeffectsanddangerousneurotoxicresponsefollowinghumanconsumption‏ ‎‡A  Hypothesizing that designer drugs containing cathinones ("bath salts") have profound neuro-inflammatory effects and dangerous neurotoxic response following human consumption‏ ‎‡9  1‏
919 ‎‡a  hypothesizingthatdesignerdrugscontainingcathinones‏ ‎‡A  Hypothesizing that designer drugs containing cathinones‏ ‎‡9  1‏
919 ‎‡a  hypothesizingthataprodopaminergicregulatorkb220ztmliquidvariantcaninducedopaminehomeostasisandprovideadjunctivedetoxificationbenefitsinopiateopioiddependence‏ ‎‡A  Hypothesizing that a Pro-Dopaminergic Regulator (KB220z™ Liquid Variant) can Induce "Dopamine Homeostasis" and Provide Adjunctive Detoxification Benefits in Opiate/Opioid Dependence‏ ‎‡9  1‏
919 ‎‡a  hypothesizingthataprodopaminergicregulator‏ ‎‡A  Hypothesizing that a Pro-Dopaminergic Regulator‏ ‎‡9  1‏
919 ‎‡a  hypothesizingrepetitiveparaphiliabehaviorofamedicationrefractivetourettessyndromepatienthavingrapidclinicalattenuationwithkb220znutrigenomicaminoacidtherapynaat‏ ‎‡A  Hypothesizing repetitive paraphilia behavior of a medication refractive Tourette's syndrome patient having rapid clinical attenuation with KB220Z-nutrigenomic amino-acid therapy (NAAT).‏ ‎‡9  1‏
919 ‎‡a  hypothesizinglasvegasandsutherlandspringsmassshooterssufferfromrewarddeficiencysyndromebornbad‏ ‎‡A  Hypothesizing Las Vegas and Sutherland Springs Mass Shooters Suffer from Reward Deficiency Syndrome: "Born Bad"‏ ‎‡9  1‏
919 ‎‡a  healingenhancementofchronicvenousstasisulcersutilizinghwaverdevicetherapyacaseseries‏ ‎‡A  Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE(R) device therapy: a case series‏ ‎‡9  1‏
919 ‎‡a  genospiritualityourbeliefsourgenomesandaddictions‏ ‎‡A  Genospirituality: Our Beliefs, Our Genomes, and Addictions‏ ‎‡9  1‏
919 ‎‡a  enhancedfunctionalconnectivityandvolumebetweencognitiveandrewardcentersofnaiverodentbrainproducedbyprodopaminergicagentkb220z‏ ‎‡A  Enhanced functional connectivity and volume between cognitive and reward centers of naïve rodent brain produced by pro-dopaminergic agent KB220Z.‏ ‎‡9  1‏
919 ‎‡a  earlyinterventionofintravenouskb220ivneuroadaptagenaminoacidtherapynaatimprovesbehavioraloutcomesinaresidentialaddictiontreatmentprogramapilotstudy‏ ‎‡A  Early intervention of intravenous KB220IV--neuroadaptagen amino-acid therapy (NAAT) improves behavioral outcomes in a residential addiction treatment program: a pilot study‏ ‎‡9  1‏
919 ‎‡a  drugabuserelapserateslinkedtolevelofeducationcanwerepairhypodopaminergicinducedcognitivedeclinewithnutrienttherapy‏ ‎‡A  Drug abuse relapse rates linked to level of education: can we repair hypodopaminergic-induced cognitive decline with nutrient therapy?‏ ‎‡9  1‏
919 ‎‡a  dopaminehomeostasisrequiresbalancedpolypharmacyissuewithdestructivepowerfuldopamineagentstocombatamericasdrugepidemic‏ ‎‡A  "Dopamine homeostasis" requires balanced polypharmacy: Issue with destructive, powerful dopamine agents to combat America's drug epidemic‏ ‎‡9  1‏
919 ‎‡a  dodopaminergicgenepolymorphismsaffectmesolimbicrewardactivationofmusiclisteningresponsetherapeuticimpactonrewarddeficiencysyndromerds‏ ‎‡A  Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS).‏ ‎‡9  1‏
919 ‎‡a  diagnosisandhealinginveteranssuspectedofsufferingfromposttraumaticstressdisorderptsdusingrewardgenetestingandrewardcircuitrynaturaldopaminergicactivation‏ ‎‡A  Diagnosis and Healing In Veterans Suspected of Suffering from Post-Traumatic Stress Disorder (PTSD) Using Reward Gene Testing and Reward Circuitry Natural Dopaminergic Activation‏ ‎‡9  1‏
919 ‎‡a  declinolacomplexcontainingkudzubitterherbsgentiantangerinepeelandbupleurumsignificantlyreducedalcoholusedisordersidentificationtestauditscoresinmoderatetoheavydrinkersapilotstudy‏ ‎‡A  Declinol, a Complex Containing Kudzu, Bitter Herbs (Gentian, Tangerine Peel) and Bupleurum, Significantly Reduced Alcohol Use Disorders Identification Test (AUDIT) Scores in Moderate to Heavy Drinkers: A Pilot Study‏ ‎‡9  1‏
919 ‎‡a  criticalanalysisofwhitehouseantidrugplan‏ ‎‡A  Critical Analysis of White House Anti-Drug Plan‏ ‎‡9  1‏
919 ‎‡a  couplinggeneticaddictionriskscoregarswithelectrotherapyfightingiatrogenicopioiddependence‏ ‎‡A  Coupling Genetic Addiction Risk Score (GARS) with Electrotherapy: Fighting Iatrogenic Opioid Dependence‏ ‎‡9  1‏
919 ‎‡a  couplinggeneticaddictionriskscoregarsandprodopamineregulationkb220tocombatsubstanceusedisordersud‏ ‎‡A  Coupling Genetic Addiction Risk Score (GARS) and Pro Dopamine Regulation (KB220) to Combat Substance Use Disorder (SUD)‏ ‎‡9  1‏
919 ‎‡a  couplinggeneticaddictionriskscore‏ ‎‡A  Coupling Genetic Addiction Risk Score‏ ‎‡9  1‏
919 ‎‡a  correlationofthetaq1dopamined2receptorgeneandpercentbodyfatinobeseandscreenedcontrolsubjectsapreliminaryreport‏ ‎‡A  Correlation of the Taq1 dopamine D2 receptor gene and percent body fat in obese and screened control subjects: a preliminary report‏ ‎‡9  1‏
946 ‎‡a  b‏ ‎‡9  1‏
996 ‎‡2  DNB|1153904888‏
996 ‎‡2  LC|n 85812229‏
996 ‎‡2  RERO|A011478511‏
996 ‎‡2  NII|DA03770875‏
996 ‎‡2  LC|no2006021139‏
996 ‎‡2  LC|no2022099027‏
996 ‎‡2  DNB|1211688496‏
996 ‎‡2  ISNI|0000000051184701‏
996 ‎‡2  BNF|14101481‏
996 ‎‡2  SUDOC|179804693‏
996 ‎‡2  ISNI|0000000001337343‏
996 ‎‡2  DNB|1231740485‏
996 ‎‡2  DNB|134986458‏
996 ‎‡2  BNF|17010997‏
996 ‎‡2  LIH|LNB:CDTK;=BC‏
996 ‎‡2  RERO|A003298189‏
996 ‎‡2  LC|no2008109038‏
996 ‎‡2  ISNI|0000000024229521‏
996 ‎‡2  LC|n 2023016228‏
996 ‎‡2  NYNYRILM|336996‏
996 ‎‡2  J9U|987007325126705171‏
996 ‎‡2  LC|n 78057982‏
996 ‎‡2  SUDOC|224870092‏
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏